These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 2326653

  • 1. Metastatic neuroblastoma: new abnormalities on bone scintigraphy may not indicate tumour recurrence.
    Hall-Craggs MA, Shaw D, Pritchard J, Gordon I.
    Skeletal Radiol; 1990; 19(1):33-6. PubMed ID: 2326653
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma.
    Shulkin BL, Shapiro B, Hutchinson RJ.
    J Nucl Med; 1992 Oct; 33(10):1735-40. PubMed ID: 1403138
    [Abstract] [Full Text] [Related]

  • 4. Does I-131-MIBG underestimate skeletal disease burden in neuroblastoma?
    Barai S, Bandopadhayaya GP, Malhotra A, Agarwal S, Kumar R, Dhanapathi H.
    J Postgrad Med; 2004 Oct; 50(4):257-60; discussion 260-1. PubMed ID: 15623965
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. False-negative scintigraphy with Tc-99m sestamibi in stage IV neuroblastoma.
    Ozcan Z, Erenel G, Aksoylar S, Kansoy S, Burak Z, Ozkiliç H.
    Clin Nucl Med; 1999 Apr; 24(4):267-70. PubMed ID: 10466525
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neuroblastoma presenting clinically as hip osteomyelitis: a "signature" diagnosis on skeletal scintigraphy.
    Applegate K, Connolly LP, Treves ST.
    Pediatr Radiol; 1995 Nov; 25 Suppl 1():S93-6. PubMed ID: 8577566
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the utility of 99m Tc-MDP bone scintigraphy versus MIBG scintigraphy and cross-sectional imaging for staging patients with neuroblastoma.
    Gauguet JM, Pace-Emerson T, Grant FD, Shusterman S, DuBois SG, Frazier AL, Voss SD.
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449267
    [Abstract] [Full Text] [Related]

  • 10. Radionuclide bone scanning in neuroblastoma: skeletal metastases and primary tumor localization of 99mTc-MDP.
    Podrasky AE, Stark DD, Hattner RS, Gooding CA, Moss AA.
    AJR Am J Roentgenol; 1983 Sep; 141(3):469-72. PubMed ID: 6224402
    [Abstract] [Full Text] [Related]

  • 11. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
    Gordon I, Peters AM, Gutman A, Morony S, Dicks-Mireaux C, Pritchard J.
    J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
    [Abstract] [Full Text] [Related]

  • 12. The complementary role of sequential 99mTc-MDP and 67Ga-citrate scanning in the diagnosis and follow-up of neuroblastoma.
    Garty I, Koren A, Goshen Y, Siplovich L.
    Eur J Nucl Med; 1985 Feb; 11(6-7):224-9. PubMed ID: 3865771
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of stage 4 neuroblastoma patients by means of MIBG and 99mTc-MDP scintigraphy.
    Turba E, Fagioli G, Mancini AF, Rosito P, Galli A, Alvisi P.
    J Nucl Biol Med (1991); 1993 Sep; 37(3):107-14. PubMed ID: 8218456
    [Abstract] [Full Text] [Related]

  • 15. Extraosseous uptake of 99mtechnetium methylene diphosphonate: neuroblastoma or radiation therapy.
    Sty JR, Kun L, Casper J, Babbitt DP.
    Pediatr Radiol; 1980 Sep; 9(1):53-4. PubMed ID: 7352114
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of morphological/immunohistochemical versus nuclear medicine imaging modalities in detecting metastatic bone and/or marrow deposits in neuroblastoma patients.
    Zaher Ael-S, Zaher AM, Moneer MM, El Gamal BM.
    J Egypt Natl Canc Inst; 2011 Jun; 23(2):79-88. PubMed ID: 22099965
    [Abstract] [Full Text] [Related]

  • 17. Differentiation of malignant and degenerative benign bone disease using Tc-99m MDP and Tc-99m citrate scintigraphy.
    Sharma R, Mondal A, Bhatnagar A, Chakravarty KL, Mishra P, Chopra MK, Rawat HS, Kashyap R.
    Clin Nucl Med; 1998 Nov; 23(11):758-63. PubMed ID: 9814564
    [Abstract] [Full Text] [Related]

  • 18. Differentiation of malignant and degenerative bone lesions using dexamethasone interventional 3- and 24-hour bone scintigraphy.
    Bhatnagar A, Mondal A, Kashyap R, Sharma RK, Sharma R, Chakravarty SK, Bihari V, Sawroop K, Chopra MK, Soni NL.
    Eur J Nucl Med; 1994 Jul; 21(7):609-14. PubMed ID: 7957346
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of metaiodobenzylguanidine as a scintigraphic agent for the detection of neuroblastoma.
    Parisi MT, Greene MK, Dykes TM, Moraldo TV, Sandler ED, Hattner RS.
    Invest Radiol; 1992 Oct; 27(10):768-73. PubMed ID: 1399431
    [Abstract] [Full Text] [Related]

  • 20. [Scintigraphy in the diagnosis and follow-up of bone neoplasms in childhood].
    Silvestro L, Testa A, Mussa GC.
    Minerva Pediatr; 1987 May 31; 39(10):463-70. PubMed ID: 2821371
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.